The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.
about
Diffusion-weighted imaging of the liver: techniques and applications.Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?Diagnostic performance of diffusion-weighted MRI for detection of pelvic metastatic lymph nodes in patients with cervical cancer: a systematic review and meta-analysisEarly survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis.The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases.Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single CeHypo-Vascular Liver Metastases Treated with Transarterial chemoembolization: Assessment of Early Response by Volumetric Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance ImagingAn overview of imaging techniques for liver metastases management.Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates.A biomimetic tumor tissue phantom for validating diffusion-weighted MRI measurements.Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.
P2860
Q30840354-19A649AF-DF29-481D-B0B3-2C68D6885519Q34207776-19EE4E22-0EAC-4D1F-BD2D-F59673C6CABBQ35674625-96429C6B-05C3-4769-95D2-5C5F2CB7B0C8Q35691040-94BE20C2-9FED-439F-87DB-8E80438950D5Q36315964-8CA4B079-3E94-4098-B9FC-D1D575ACB537Q37082835-DCB2BB6E-DEEE-449E-9947-D1DE21127DBDQ37206772-EF3A46FE-C050-4DE0-BC1F-943FC583E233Q37221919-5FA9F0E2-3548-45CD-A03F-BAE93339B3BDQ38594431-C413E127-E843-402C-B22E-AD5EFB6E5F10Q42085639-27C4D300-8AC5-450E-B27D-8F9AF281557AQ47790176-733744C3-15A7-4F0D-AD99-6C3200173ABFQ52889145-E66D0E3C-8618-4371-BD1F-31BB7D7AAE8BQ53000448-3B9D18B1-DD7D-4ADC-88BE-C15553760519
P2860
The role of pre-treatment diffusion-weighted MRI in predicting long-term outcome of colorectal liver metastasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of pre-treatment diff ...... f colorectal liver metastasis.
@en
The role of pre-treatment diff ...... f colorectal liver metastasis.
@nl
type
label
The role of pre-treatment diff ...... f colorectal liver metastasis.
@en
The role of pre-treatment diff ...... f colorectal liver metastasis.
@nl
prefLabel
The role of pre-treatment diff ...... f colorectal liver metastasis.
@en
The role of pre-treatment diff ...... f colorectal liver metastasis.
@nl
P2860
P50
P356
P1476
The role of pre-treatment diff ...... of colorectal liver metastasis
@en
P2860
P304
P356
10.1259/BJR.20130281
P407
P577
2013-08-30T00:00:00Z